BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 16943725)

  • 1. De-escalation therapy in ventilator-associated pneumonia.
    Niederman MS
    Curr Opin Crit Care; 2006 Oct; 12(5):452-7. PubMed ID: 16943725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.
    Leone M; Garcin F; Bouvenot J; Boyadjev I; Visintini P; Albanèse J; Martin C
    Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventilator-associated pneumonia: an overview.
    DiCocco JM; Croce MA
    Expert Opin Pharmacother; 2009 Jun; 10(9):1461-7. PubMed ID: 19505213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of ventilator-associated pneumonia caused by multiresistant bacteria.
    Diaz E; Muñoz E; Agbaht K; Rello J
    Curr Opin Crit Care; 2007 Feb; 13(1):45-50. PubMed ID: 17198048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?
    Niederman MS; Soulountsi V
    Clin Chest Med; 2011 Sep; 32(3):517-34. PubMed ID: 21867820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microbiological monitoring of ventilator-associated pneumonia in an intensive care unit].
    Joost I; Lange C; Seifert H
    Dtsch Med Wochenschr; 2010 Feb; 135(5):197-202. PubMed ID: 20104440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumonia.
    Niederman MS
    Semin Respir Crit Care Med; 2006 Feb; 27(1):45-50. PubMed ID: 16508881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design.
    Niederman MS
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S12-7. PubMed ID: 20597660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for nosocomial pneumonia due to MRSA.
    Niederman MS
    J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.
    Heyland DK; Dodek P; Muscedere J; Day A; Cook D;
    Crit Care Med; 2008 Mar; 36(3):737-44. PubMed ID: 18091545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia?
    Pea F; Viale P
    J Trauma; 2009 Oct; 67(4):893-4; author reply 894-5. PubMed ID: 19820604
    [No Abstract]   [Full Text] [Related]  

  • 13. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.
    Alvarez-Lerma F; Alvarez B; Luque P; Ruiz F; Dominguez-Roldan JM; Quintana E; Sanz-Rodriguez C;
    Crit Care; 2006; 10(3):R78. PubMed ID: 16704742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intensive care unit in antimicrobial resistance.
    Koleff MH
    Postgrad Med; 2001 Feb; 109(2 Suppl):60-9. PubMed ID: 19667559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical approach to the patient with suspected ventilator-associated pneumonia.
    Vidaur L; Sirgo G; Rodríguez AH; Rello J
    Respir Care; 2005 Jul; 50(7):965-74; discussion 974. PubMed ID: 15972116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines.
    Kuti JL; Shore E; Palter M; Nicolau DP
    Semin Respir Crit Care Med; 2009 Feb; 30(1):102-15. PubMed ID: 19199192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventilator-associated pneumonia: a review.
    Davis KA
    J Intensive Care Med; 2006; 21(4):211-26. PubMed ID: 16855056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries.
    Lagamayo EN
    Am J Infect Control; 2008 May; 36(4 Suppl):S101-8. PubMed ID: 18468549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
    Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.